These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12377193)

  • 21. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
    Cao L; Liu Y; During MJ; Xiao W
    J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL; Liu PS; Wu CL
    J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of adeno-associated virus packaging plasmids and cells that directly select for AAV helper functions.
    Whiteway A; Deru W; Prentice HG; Anderson R
    J Virol Methods; 2003 Dec; 114(1):1-10. PubMed ID: 14599673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing recombinant adeno-associated virus production.
    Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
    Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production.
    Allen JM; Debelak DJ; Reynolds TC; Miller AD
    J Virol; 1997 Sep; 71(9):6816-22. PubMed ID: 9261406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.
    Philpott NJ; Giraud-Wali C; Dupuis C; Gomos J; Hamilton H; Berns KI; Falck-Pedersen E
    J Virol; 2002 Jun; 76(11):5411-21. PubMed ID: 11991970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific integration of an adeno-associated virus vector plasmid mediated by regulated expression of rep based on Cre-loxP recombination.
    Satoh W; Hirai Y; Tamayose K; Shimada T
    J Virol; 2000 Nov; 74(22):10631-8. PubMed ID: 11044107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
    Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
    Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector production.
    Li C; Samulski RJ
    Virology; 2005 Apr; 335(1):10-21. PubMed ID: 15823602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
    Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel tools for production and purification of recombinant adenoassociated virus vectors.
    Grimm D; Kern A; Rittner K; Kleinschmidt JA
    Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cis effects in adeno-associated virus type 2 replication.
    Ward P; Clément N; Linden RM
    J Virol; 2007 Sep; 81(18):9976-89. PubMed ID: 17626079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production.
    Martin J; Frederick A; Luo Y; Jackson R; Joubert M; Sol B; Poulin F; Pastor E; Armentano D; Wadsworth S; Vincent K
    Hum Gene Ther Methods; 2013 Aug; 24(4):253-69. PubMed ID: 23848282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus].
    Wu Z; Wu X; Hou Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar; 16(1):74-8. PubMed ID: 11986753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OneBac 2.0: Sf9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA.
    Mietzsch M; Casteleyn V; Weger S; Zolotukhin S; Heilbronn R
    Hum Gene Ther; 2015 Oct; 26(10):688-97. PubMed ID: 26134901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
    Grimm D; Kay MA; Kleinschmidt JA
    Mol Ther; 2003 Jun; 7(6):839-50. PubMed ID: 12788658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adeno-associated virus type 2 Rep40 modulates the proliferation rate of Rep52-expressing HeLa cells.
    Li D; Kashii S; Sahara T; Ito K
    Intervirology; 2003; 46(2):127-34. PubMed ID: 12684552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector.
    Liu Q; Perez CF; Wang Y
    J Virol; 2006 Feb; 80(4):1672-9. PubMed ID: 16439524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.